Literature DB >> 1540436

Long-term course and cardiac sympathetic nerve activity in patients with hypertrophic cardiomyopathy.

M Shimizu1, N Sugihara, Y Kita, K Shimizu, Y Horita, K Nakajima, J Taki, R Takeda.   

Abstract

OBJECTIVE: To investigate the relation between regional myocardial sympathetic nerve activity and the electrocardiographic and cardiac functional changes in hypertrophic cardiomyopathy.
DESIGN: A retrospective study to compare the findings of myocardial scintigraphy with iodine-123 metaiodobenzylguanidine (MIBG) and the serial electrocardiographic changes.
SETTING: Myocardial scintigraphy was performed with iodine-123 MIBG and thallium-201 and single photon emission computed tomography (SPECT) in the division of nuclear medicine of Kanazawa University Hospital. Both SPECT studies were performed within a week. PATIENTS: 22 patients with hypertrophic cardiomyopathy classified according to their serial electrocardiographic changes--namely, 15 patients with an increase in or the appearance of a negative T wave (group A) and seven patients with a conduction disturbance or a decrease in or disappearance of the negative T wave (group B). The mean follow up period was 45 (range 12-143) months.
RESULTS: Group B showed a high rate of decreased activity or defects in MIBG uptake compared with group A (p less than 0.005). The areas of decreased activity or defects corresponded with the hypertrophied portion of the left ventricular wall. Although the early myocardial uptake (MIBG: thallium ratio) was similar in both groups, the mean (SD) MIBG clearance rate was significantly higher (p less than 0.05) in group B (0.25 (0.17)) than in group A (0.10 (0.15)).
CONCLUSION: Abnormalities of regional myocardial sympathetic nerve activity may be important in patients with hypertrophic cardiomyopathy and suspected progression of myocardial damage.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1540436      PMCID: PMC1024746          DOI: 10.1136/hrt.67.2.155

Source DB:  PubMed          Journal:  Br Heart J        ISSN: 0007-0769


  29 in total

1.  De subitaneis mortibus. XII. Asymmetrical hypertrophy of the heart.

Authors:  T N James; T K Marshall
Journal:  Circulation       Date:  1975-06       Impact factor: 29.690

2.  Serial electrocardiographic and angiographic changes of patients with hypertrophic cardiomyopathy.

Authors:  Y Horita; A Genda; M Shimizu; N Sugihara; T Suematsu; Y Kita; R Takeda
Journal:  Jpn Circ J       Date:  1989-11

3.  Occurrence and significance of progressive left ventricular wall thinning and relative cavity dilatation in hypertrophic cardiomyopathy.

Authors:  P Spirito; B J Maron; R O Bonow; S E Epstein
Journal:  Am J Cardiol       Date:  1987-07-01       Impact factor: 2.778

4.  The natural history of left ventricular hypertrophy in hypertrophic cardiomyopathy: an electrocardiographic study.

Authors:  W J McKenna; M Borggrefe; D England; J Deanfield; C M Oakley; J F Goodwin
Journal:  Circulation       Date:  1982-12       Impact factor: 29.690

5.  Myocardial imaging with a radioiodinated norepinephrine storage analog.

Authors:  D M Wieland; L E Brown; W L Rogers; K C Worthington; J L Wu; N H Clinthorne; C A Otto; D P Swanson; W H Beierwaltes
Journal:  J Nucl Med       Date:  1981-01       Impact factor: 10.057

6.  Pathophysiology of chest pain in patients with cardiomyopathies and normal coronary arteries.

Authors:  A Pasternac; J Noble; Y Streulens; R Elie; C Henschke; M G Bourassa
Journal:  Circulation       Date:  1982-04       Impact factor: 29.690

7.  Effects of propranolol on myocardial oxygen consumption, substrate extraction, and haemodynamics in hypertrophic obstructive cardiomyopathy.

Authors:  D S Thompson; N Naqvi; S M Juul; R H Swanton; D J Coltart; B S Jenkins; M M Webb-Peploe
Journal:  Br Heart J       Date:  1980-11

8.  Abnormal I-123 metaiodobenzylguanidine myocardial washout and distribution may reflect myocardial adrenergic derangement in patients with congestive cardiomyopathy.

Authors:  E B Henderson; J K Kahn; J R Corbett; D E Jansen; J J Pippin; P Kulkarni; V Ugolini; M S Akers; C Hansen; L M Buja
Journal:  Circulation       Date:  1988-11       Impact factor: 29.690

9.  Progression from hypertrophic obstructive cardiomyopathy to typical dilated cardiomyopathy-like features in the end stage.

Authors:  H Fujiwara; T Onodera; M Tanaka; H Shirane; H Kato; J Yoshikawa; G Osakada; S Sasayama; C Kawai
Journal:  Jpn Circ J       Date:  1984-11

10.  Thallium perfusion and cardiac enzyme abnormalities in patients with familial hypertrophic cardiomyopathy.

Authors:  S Nagata; Y Park; T Minamikawa; C Yutani; T Kamiya; T Nishimura; T Kozuka; H Sakakibara; Y Nimura
Journal:  Am Heart J       Date:  1985-06       Impact factor: 4.749

View more
  8 in total

Review 1.  MIBG imaging.

Authors:  Amar D Patel; Ami E Iskandrian
Journal:  J Nucl Cardiol       Date:  2002 Jan-Feb       Impact factor: 5.952

2.  123I-MIBG myocardial imaging in hypertensive patients: abnormality progresses with left ventricular hypertrophy.

Authors:  I Mitani; S Sumita; N Takahashi; H Ochiai; M Ishii
Journal:  Ann Nucl Med       Date:  1996-08       Impact factor: 2.668

Review 3.  Cardiac 123I-mIBG Imaging in Heart Failure.

Authors:  Derk O Verschure; Kenichi Nakajima; Hein J Verberne
Journal:  Pharmaceuticals (Basel)       Date:  2022-05-25

4.  Influence of prolonged exercise on myocardial distribution of 123I-MIBG in long-distance runners.

Authors:  M Estorch; R Serra-Grima; I Carrió; A Flotats; A Lizárraga; L L Bernà; T Prats; R Segura
Journal:  J Nucl Cardiol       Date:  1997 Sep-Oct       Impact factor: 5.952

5.  Scintigraphic evidence for cardiac sympathetic dysinnervation in long-term IDDM patients with and without ECG-based autonomic neuropathy.

Authors:  O Schnell; C M Kirsch; J Stemplinger; M Haslbeck; E Standl
Journal:  Diabetologia       Date:  1995-11       Impact factor: 10.122

6.  Cardiac sympathetic nerve activity in patients with hypertrophic cardiomyopathy with malignant ventricular tachyarrhythmias.

Authors:  Hidenobu Terai; Masami Shimizu; Hidekazu Ino; Masato Yamaguchi; Kenshi Hayashi; Kenji Sakata; Masaru Kiyama; Tatsumi Hayashi; Masaru Inoue; Junichi Taki; Hiroshi Mabuchi
Journal:  J Nucl Cardiol       Date:  2003 May-Jun       Impact factor: 5.952

Review 7.  Differential Role of Leptin and Adiponectin in Cardiovascular System.

Authors:  C M Ghantous; Z Azrak; S Hanache; W Abou-Kheir; A Zeidan
Journal:  Int J Endocrinol       Date:  2015-05-03       Impact factor: 3.257

Review 8.  Cardiac sympathetic activity in hypertrophic cardiomyopathy and Tako-tsubo cardiomyopathy.

Authors:  Derk O Verschure; Berthe L F van Eck-Smit; G Aernout Somsen; Hein J Verberne
Journal:  Clin Transl Imaging       Date:  2015-08-04
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.